Arverne Group Act

As of December 31, 2025, Arverne Group Act carries a market capitalization of 206.03M, placing it among publicly traded companies globally. Its enterprise value stands at 183.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Arverne Group Act's next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, Arverne Group Act has 42.05M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 10.82, and the price-to-book ratio stands at 1.46.

These figures are as of December 31, 2025. The EV/Sales ratio of 10.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 183.09M versus a market cap of 206.03M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Arverne Group Act maintains a current ratio of 2.75, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.32, indicating elevated leverage, while an interest coverage ratio of -25.06 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, Arverne Group Act posted a negative return on equity (ROE) of -13.97, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -8.35, reflecting losses generated across the asset base. Inventory turnover of -2.30 indicates how many times Arverne Group Act sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, Arverne Group Act recorded an income tax benefit of -1.50M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -25.06M and -20.71M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Arverne Group Act's stock has gained approximately 22.38% over the past 52 weeks. The 50-day moving average sits at 6.90, while the 200-day moving average is 6.78.

Over the twelve months ended December 31, 2025, Arverne Group Act generated 18.28M in revenue and converted that into -20.71M in net income, yielding earnings per share of -0.58. EBITDA reached -21.35M, while operating income came in at -25.10M.

As of December 31, 2025, Arverne Group Act holds 78.06M in cash and equivalents against 37.02M in total debt, resulting in a net debt position of -70.37M. Total book value stands at 140.65M, with working capital of 64.37M providing operational flexibility.

Arverne Group Act produced -13.85M in operating cash flow over the twelve months ended December 31, 2025. After subtracting -6.24M in capital expenditures, free cash flow totaled -20.09M - equivalent to -0.50 per share.

Over the twelve months ended December 31, 2025, Arverne Group Act posted a gross margin of 131.15, reflecting its pricing power and cost economics. The operating margin of -137.28 and net profit margin of -113.29 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -10.15: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.17, meaning Arverne Group Act raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of December 31, 2025, Arverne Group Act has an Altman Z-Score of 0.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.